Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals Lp.

Procedural entryThis page is a short order in Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals Lp.. Read the opinion of the Court — 661 F.3d 1378
Court of Appeals for the Federal Circuit·Decided May 19, 2011·No. 2011-1091·Unpublished

Opinion

NOTE: This order is nonprecedential United States Court of AppeaIs for the FederaI Circuit TEVA PHARMACEUTICAL INDUSTRIES LTD., Plaintiff-Appellan,t, ' V. ASTRAZENECA PHARMACEUTICALS LP AND IPR PHARMACEUTICALS INC., Defen,dan,ts-Appellees. 2011-1091_ ` Appea1 from the United States District Cou1't for the Eastern District of Pennsy1vania in case no. 08-CV-4786, Judge Wi11iam H. Yohn, Jr. ON MOTION ORDER Teva Pharmaceutica1 Industries Ltd. moves for an ex- tension of ti1ne, until May 26, 2011, to file the joint ap- pendix. TeVa also moves to withdraw John L. North, Jeffrey J. Toney, Jonathan K. Waldrop, and Darcy L. Jones, as counsel of record and to substitute Jeffrey D. B1ake as principal counsel Upon consideration thereof

TEVA PHARMA V. ASTRAZENECA PHARMA CC. S IT Is ORDERED THAT: 2 The motions are granted Jeffrey D. Blake should promptly file an entry of appearance as principal counsel. FOR THE COURT l‘lAY 1 9 ?9ll 131 Jan H0rba1y Date J an Horbaly Clerk Jeffrey D. Blake, Esq. John L. North, Esq. B'S'l`HE'l'!E Darcy L. Jones, ESq §-?.§: §2=~; i’“ §_>Y'= EAL8 FOR RCU1T Jeffrey J. Toney, Esi1. MAY` 1 go Jonathan K. Waldrop, Esq. Eric Jay Fues, Esq. -lANmRBALY 21 __

Free access — add to your briefcase to read the full text and ask questions with AI

Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals Lp., (Fed. Cir. 2011).

Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals Lp. (Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals Lp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.